A core pillar of treatment for patients with heart failure with LVEF ≥40% ++

https://www.statnews.com/sponsor/2025/11/01/a-core-pillar-of-treatment-for-patients-with-heart-failure-with-lvef-40/ CRISPR-based treatment cuts cholesterol and triglycerides in early study Researchers are excited about therapy’s potential but say much more safety data are needed https://www.statnews.com/2025/11/08/crispr-therapeutics-cholesterol-lowering-gene-editing-study/